CTDC Announces the Disposal of Non-cor... ( HONG KONG Dec. 20 /Xinhua-- China...)

CTDC Announces the Disposal of Non-core Business

Date:12/20/2007

HONG KONG, Dec. 20 /Xinhua-PRNewswire-FirstCall/ -- China Technology Development Group Corporation (Nasdaq: CTDC, "the Company" or "CTDC"), a provider of clean and renewable energy products and solutions focusing on solar energy business in China, today announced that it has completed another step in its strategic plan to focus the Company's management and operating resources on the principal business of solar energy.

On December 18, 2007, the Company disposed its subsidiary China Natures Technology Inc. ("China Natures") to an independent party for a total cash consideration of HK$10,000,000, pursuant to the sale and purchase agreement dated December 18, 2007 ("SPA"). The disposal of China Natures and the major terms of the SPA have been approved by the shareholders on the annual general meeting held on October 19, 2007. The net proceeds of the disposal will be used to further develop its core businesses.

Alan Li, Chairman and CEO of CTDC said, "The disposal of non-core business further advances our strategy of reshaping the Company around clean renewable energy sector which presents an exciting growth opportunity for the Company and our shareholders. This transaction will allow increased focus of management and financial resources on our core activities and will put the Company in a stronger position to move forward in the solar energy business."

About CTDC:

CTDC is a provider of clean and renewable energy products and solutions in the solar energy business in China. CTDC's ultimate principal shareholder is China Merchants Group ( http://www.cmhk.com ), one of the biggest state-owned conglomerates in China. For more information, please visit our website at http://www.chinactdc.com .

Forward-Looking Statement Disclosure:

This press release of the Company, which is a foreign private issuer, on Form 6-K contains forward
'/>"/>

SOURCE China Technology Development Group Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:

(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...

(Date:1/14/2014)... Washington, DC (PRWEB) January 14, 2014 ... session for Thursday, January 23, 2014 at 2pm EST ... Actionable Knowledge.” The topic focuses on how technology can ... mission critical decisions for government agencies. The online webinar ...

(Date:1/14/2014)... leading provider of strategic communications services to corporations and organizations preparing ... the United States and Europe , ... returning to the firm,s Washington, D.C. office. ... two years of service as Associate Commissioner for the Office of ...

(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...

Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2 TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3 TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4 Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2 Former FDA Associate Commissioner Returns To 3D Communications 2 EquitiesIQ Initiates Coverage of Alliqua, Inc. 2 EquitiesIQ Initiates Coverage of Alliqua, Inc. 3

[0] TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R))[0] Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services [0] Former FDA Associate Commissioner Returns To 3D Communications [0] EquitiesIQ Initiates Coverage of Alliqua, Inc.

... , , ... By Susan Catalano, Ph.D., Acumen Pharmaceuticals, Sylvia de Bruin, Joe Bosworth, ... Corporation, , 1311 Orleans Drive, Sunnyvale, CA 94089. , ... G-protein coupled receptors (GPCRs are the largest class of pharmaceutical ...

... and Ario de Marco , EMBL Protein Expression ... , Introduction ,Immobilized Metal ion Affinity ... that allows the fast separation of His-tagged proteins ... resins but all of them show some affinity ...

... , ,,Application Guide, ,I. Description ,II. Product ... User ,IV. Protocol for Extraction of DNA from ... from Plant ,VI. Quantification of Amplified Products ... References , Contact Information , , ,Application Guide, , ...

High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system Double-Affinity Purification of GST-His Tagged Proteins Using Vivapure 8-to-96 Well Cobalt-Chelate Kit Protocol for GenomePlex Whole Genome Amplification from Plant

(Date:4/17/2014)... on a novel method to help kidney stone ... effective treatment possible., Kidney stones represent a major ... If left untreated, apart from being particularly painful, ... complications. In many patients treated successfully, stone recurrence ... pathological approach to diagnosis and treatment needs to ...

(Date:4/17/2014)... have detected new early-warning signs of the potential loss ... far-reaching implications for the diagnosis and treatment of diabetic ... Americans. , "We had not expected to see such ... said Ann Elsner, professor and associate dean in the ... study. "We set out to study the early signs, ...

(Date:4/17/2014)... immune system may fight cancers and viral infections. The ... treat illness. , The research, in mice, suggests that ... specialized squads of defenders that patrol only one ... the body. , Scientists at Washington University School of ... skin and uterus each has dedicated immune cells, which ...

Breaking Biology News(10 mins):New technique detects microscopic diabetes-related eye damage 2 New technique detects microscopic diabetes-related eye damage 3 Some immune cells defend only 1 organ 2

[0] More effective kidney stone treatment, from the macroscopic to the nanoscale [0] New technique detects microscopic diabetes-related eye damage [0] Some immune cells defend only 1 organ

... in Plant Science Automated conserved ... promoter evolution among grasses Within the genome of ... undergo little change in position and sequence over millions of ... these evolutionarily stable sequences, so-called conserved noncoding sequences (CNSs), are ...

... Investigators at Rollins School of Public Health at Emory ... Technology, have received a $4 million grant over four ... (Health and Exposome Research Center: Understanding Lifetime Exposures). The ... the United States. The HERCULES Center is ...

... or harsh treatments because science fails to identify ... the disease. Researchers at Case Western Reserve University ... that allows patients to safely choose to do ... drastic measures. The project is one of ...

Cached Biology News:Frontiers news briefs: May 23 2 Frontiers news briefs: May 23 3 Emory, Georgia Tech receive first human exposome center grant in US 2 Emory, Georgia Tech receive first human exposome center grant in US 3 Using big data to identify prostate cancers and best treatments 2 Using big data to identify prostate cancers and best treatments 3

Frontiers news briefs: May 23 Emory, Georgia Tech receive first human exposome center grant in US Using big data to identify prostate cancers and best treatments

... Microarrays designed for genome-wide microRNA expression profiling ... Paraflo microfluidic on-chip synthesis platform. These microarrays ... microRNA Expression Profiling Service. Probe ... all known cow microRNAs (108 unique mature ...

... for genome-wide microRNA expression profiling and ... Paraflo microfluidic on-chip synthesis platform. These ... our comprehensive microRNA Expression Profiling Service. ... Viruses microRNA Microarray contains all known ...

...

... The Agilent 6850 Networked GC is an excellent ... footprint of a standard dual-channel GC, this one-channel ... GCs in the space of one. You get ... routine GC analyses in an instrument that has ...

Biology Products:

Cow microRNA Microarray from LC Sciences Viruses microRNA Microarray from LC Sciences Benchtop Laminar Hood (Universal Hood) from Terra Universal, Inc.6850 Networked GC from Agilent Technologies